logo-loader
CSE:INNO

InnoCan Pharma

Receive alerts
Market:
CSE
Market Cap:
$24.46 m
Price
0.17 CAD
Change
-5.56%
52 weeks high
0.40
52 weeks low
0.05

In brief

Innocan Pharma™ combines pharmaceutical experience with technological innovation to deliver the new generation of CBD integrated pharma and cosmetics products.

Deep dive We explore the investor case for growth companies

Snapshot

The Liposome Platform Technology has potential to become a licensing platform to large pharmaceutical companies either for CBD dosage or their own specific needs